Development of an optimized SEC method for characterization of genome DNA leakage from adeno-associated virus products
- 1 November 2024
- journal article
- research article
- Published by Springer Nature in Analytical and Bioanalytical Chemistry
- Vol. 416 (29) , 7173-7182
Abstract
Adeno-associated virus (AAV) vectors are widely used to deliver therapeutic transgenes due to their superior safety, relatively low immunogenicity, and ability to target diverse tissues. AAV gene therapy products are typically formulated as frozen liquid and stored below − 60 °C, and therefore are subjected to multiple freeze/thaw cycles during manufacturing and administration. Recent studies have shown that genome DNA leakage could be induced by freeze/thaw stress. DNA leakage from AAV capsids has been reported to potentially impact product stability, induce immune responses, and compromise product efficacy. Thus, further characterization to improve the understanding of genome DNA leakage is necessary for mitigating the risks associated with genome DNA leakage during AAV product development. In this work, we developed an optimized size-exclusion chromatography (SEC) method for quantifying the leakage of genome DNA across multiple different AAV serotypes and demonstrated satisfactory assay performance in sensitivity, precision, and linearity. Furthermore, we showed that this method could also be applied to quantifying additional quality attributes of AAV, including the percentage of full capsids and quantification of AAV dimers. By using this optimized SEC method, we demonstrated that significantly increased free DNA was observed with increasing freeze/thaw cycles or at a temperature approaching the onset temperature for genome DNA ejection, which was effectively mitigated by the addition of 1.5% w/v sucrose in the AAV formulation. Thus, this optimized SEC method can serve as an invaluable tool for AAV formulation, product, and process development in ensuring the quality and stability of AAV gene therapy products. Graphical AbstractKeywords
This publication has 35 references indexed in Scilit:
- Multi-attribute analysis of adeno-associated virus by size exclusion chromatography with fluorescence and triple-wavelength UV detectionAnalytical Biochemistry, 2023
- The ice age – A review on formulation of Adeno-associated virus therapeuticsEuropean Journal of Pharmaceutics and Biopharmaceutics, 2023
- Poloxamer 188 as surfactant in biological formulations – An alternative for polysorbate 20/80?International Journal of Pharmaceutics, 2022
- Genome DNA leakage of Adeno–Associated virus under freeze–thaw stressInternational Journal of Pharmaceutics, 2022
- Key considerations in formulation development for gene therapy productsDrug Discovery Today, 2022
- Quality Control Testing, Characterization and Critical Quality Attributes of Adeno‐Associated Virus Vectors Used for Human Gene TherapyBiotechnology Journal, 2020
- Cellular transduction mechanisms of adeno-associated viral vectorsCurrent Opinion in Virology, 2016
- Key interactions of surfactants in therapeutic protein formulations: A reviewEuropean Journal of Pharmaceutics and Biopharmaceutics, 2015
- Protein-Silicone Oil Interactions: Comparative Effect of Nonionic Surfactants on the Interfacial Behavior of a Fusion ProteinPharmaceutical Research, 2013
- Glass-forming property of the system diethyl sulphoxide/water and its cryoprotective action on Escherichia coli survivalCryobiology, 2004